Compass Therapeutics Stock Profit Margin
| CMPX Stock | USD 1.50 0.01 0.67% |
Compass Therapeutics fundamentals help investors to digest information that contributes to Compass Therapeutics' financial success or failures. It also enables traders to predict the movement of Compass Stock. The fundamental analysis module provides a way to measure Compass Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Compass Therapeutics stock.
| Last Reported | Projected for Next Year |
Compass | Profit Margin |
Compass Therapeutics Company Profit Margin Analysis
Compass Therapeutics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Compass Therapeutics has a Profit Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Compass Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Compass Therapeutics' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Compass Therapeutics could also be used in its relative valuation, which is a method of valuing Compass Therapeutics by comparing valuation metrics of similar companies.Compass Therapeutics is currently under evaluation in profit margin category among its peers.
Compass Fundamentals
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.22 | ||||
| Operating Margin | (65.23) % | ||||
| Current Valuation | 76.48 M | ||||
| Shares Outstanding | 137.59 M | ||||
| Shares Owned By Insiders | 12.04 % | ||||
| Shares Owned By Institutions | 69.19 % | ||||
| Number Of Shares Shorted | 1.79 M | ||||
| Price To Book | 1.48 X | ||||
| Price To Sales | 241.19 X | ||||
| EBITDA | (48.47 M) | ||||
| Net Income | (42.49 M) | ||||
| Cash And Equivalents | 132.02 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 1.73 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 12.36 X | ||||
| Book Value Per Share | 1.01 X | ||||
| Cash Flow From Operations | (40.62 M) | ||||
| Short Ratio | 3.71 X | ||||
| Earnings Per Share | (0.35) X | ||||
| Target Price | 8.0 | ||||
| Number Of Employees | 32 | ||||
| Beta | 0.75 | ||||
| Market Capitalization | 205.01 M | ||||
| Total Asset | 156.88 M | ||||
| Retained Earnings | (315.31 M) | ||||
| Working Capital | 146.08 M | ||||
| Net Asset | 156.88 M |
About Compass Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Compass Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Compass Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Compass Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Compass Stock Analysis
When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.